Omnicomm Systems Inc (OTC:OMCM)

OmniComm Systems, Inc., a healthcare technology company, provides Web-based electronic data capture (EDC) and eClinical software and services to pharmaceutical and biotech companies, clinical research organizations, and other clinical trial sponsors primarily in the United States and Europe. The company’s products include TrialMaster, which allows organizations conducting clinical trials to collect and manage the data over the World Wide Web; TrialBuilder, a tool to model a clinical study, including data collection forms, the data consistency rules, and the visit schedule, as well as the workflow and security rules for accessing and managing the data; TrialMaster Archive, which enables the clients and the U.S. Food and Drug Administration to review clinical trial data by trial, site, patient, visit, and by form parameters; and TrialMaster Safety that allows data about serious adverse events to be automatically collated and transmitted to an external safety reporting system. Its products also include TrialOne, which provides clinical trial site sponsors, study investigators, and study monitors with tools to enhance the Phase I operation; and eClinical software suite that allows clinical trial sponsors and investigative sites to collect, validate, transmit, and analyze clinical study data. In addition, the company offers consulting and professional services, such as custom configuration, training, system integration, standard operating procedures and implementation assistance, database setup, installation, and validation services, as well as application hosting and support services. It sells products through its direct sales force, as well as through its relationships with clinical research organizations. The company was founded in 1996 and is headquartered in Fort Lauderdale, Florida.